JAMA Oncology, 6(11), 1733-1740. American Medical Association JAMA Oncol van Roessel, S, van Veldhuisen, E, Klompmaker, S, Janssen, Q P, Abu Hilal, M, Alseidi, A, Balduzzi, A, Balzano, G, Bassi, C, Berrevoet, F, Bonds, M, Busch, O R, Butturini, G, Del Chiaro, M, Conlon, K C, Falconi, M, Frigerio, I, Fusai, G K, Gagnière, J, Griffin, O, Hackert, T, Halimi, A, Klaiber, U, Labori, K J, Malleo, G, Marino, M V, Mortensen, M B, Nikov, A, Lesurtel, M, Keck, T, Kleeff, J, Pandé, R, Pfeiffer, P, Pietrasz, D, Roberts, K J, Sa Cunha, A, Salvia, R, Strobel, O, Tarvainen, T, Bossuyt, P M, van Laarhoven, H W M, Wilmink, J W, Groot Koerkamp, B, Besselink, M G & European-African Hepato-Pancreato-Biliary Association 2020, ' Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment ', JAMA Oncology, vol. 6, no. 11, 1733-1740, pp. 1733-1740 . https://doi.org/10.1001/jamaoncol.2020.3537 JAMA oncology, 6(11), 1733-1740. American Medical Association